LORA JANNETTE MCGILL

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology MEMPHIS, TN NPI 1891995213

General Payments — all program years on this page

$18,115.43

  • Category: General Payments
  • Program years: PY2018–2023
  • Record count: 48
  • As of (CMS publication): 2026-01-23

Latest program year (PY2023): $2,820.19 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2023) · sorted by reported total.

Nature of paymentAmountRecords
Travel and Lodging $2,105.447
Food and Beverage $714.7512

By paying entity

Latest program year (PY2023) · sorted by reported total.

Paying entityAmountRecords
Sage Therapeutics, Inc. $1,987.8311
Alnylam Pharmaceuticals Inc. $832.368

By program year

Program yearAmountRecords
2018 $831.2511
2019 $6,202.789
2020 $3,622.673
2021 $4,465.034
2022 $173.512
2023 $2,820.1919

Records — PY2023 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1006116473 Alnylam Pharmaceuticals Inc. $196.96 01/30/2023 Travel and Lodging Undisputed 01/23/2026 View at CMS
1006116477 Alnylam Pharmaceuticals Inc. $20.13 01/30/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1006116481 Alnylam Pharmaceuticals Inc. $130.68 01/30/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1006116485 Alnylam Pharmaceuticals Inc. $66.70 01/30/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1006116489 Alnylam Pharmaceuticals Inc. $32.21 01/30/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1006116493 Alnylam Pharmaceuticals Inc. $87.12 01/30/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1006116497 Alnylam Pharmaceuticals Inc. $37.55 01/30/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1006116501 Alnylam Pharmaceuticals Inc. $261.01 01/30/2023 Travel and Lodging Undisputed 01/23/2026 View at CMS
1017096007 Sage Therapeutics, Inc. $30.00 06/11/2023 Travel and Lodging Undisputed 01/23/2026 View at CMS
1017096011 Sage Therapeutics, Inc. $15.36 06/11/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1017096859 Sage Therapeutics, Inc. $150.00 06/09/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1017097507 Sage Therapeutics, Inc. $113.89 06/09/2023 Travel and Lodging Undisputed 01/23/2026 View at CMS
1017097721 Sage Therapeutics, Inc. $50.00 06/10/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1017097987 Sage Therapeutics, Inc. $72.00 06/11/2023 Travel and Lodging Undisputed 01/23/2026 View at CMS
1017098283 Sage Therapeutics, Inc. $632.76 06/11/2023 Travel and Lodging Undisputed 01/23/2026 View at CMS
1017100283 Sage Therapeutics, Inc. $798.82 06/09/2023 Travel and Lodging Undisputed 01/23/2026 View at CMS
1017100607 Sage Therapeutics, Inc. $37.50 06/10/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1017101417 Sage Therapeutics, Inc. $37.50 06/10/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1017103711 Sage Therapeutics, Inc. $50.00 06/10/2023 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.